Further study by the same group revealed that GLI1 regulates the expression of EMT-inducing transcription factors, TWIST1 and SNAI1, to promote tumor-initiating cell-like properties and consequently chemoresistance in the resistant sublines. The gene discussed is TWIST1; the disease is neoplasm.